Mild Dementia Clinical Trials

11 recruiting

Mild Dementia Trials at a Glance

11 actively recruiting trials for mild dementia are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Malmö, Gainesville, and Guri-si. Lead sponsors running mild dementia studies include Skane University Hospital, NYU Langone Health, and Ludwig-Maximilians - University of Munich.

Browse mild dementia trials by phase

Treatments under study

About Mild Dementia Clinical Trials

Looking for clinical trials for Mild Dementia? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Mild Dementia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Mild Dementia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Not Applicable

Transcranial Pulse Stimulation of the Brain

Mild DementiaAging Well
University of Florida20 enrolled1 locationNCT05910619
Recruiting

The Swedish BioFINDER - Primary Care Study

Alzheimer DiseaseMild Cognitive ImpairmentLewy Body Disease+4 more
Skane University Hospital1,200 enrolled1 locationNCT06120361
Recruiting

The Swedish BioFINDER - Memory Clinic Study

Alzheimer DiseaseMild Cognitive ImpairmentLewy Body Disease+4 more
Skane University Hospital1,200 enrolled1 locationNCT06122415
Recruiting

The Swedish BioFINDER - Preclinical AD Study

Alzheimer DiseaseMild Cognitive ImpairmentMild Dementia
Skane University Hospital800 enrolled1 locationNCT06121544
Recruiting

Dementia-friendly Apothecaries as a Resource for Mental Heath in the Elderly

Mild Cognitive ImpairmentMild Dementia
Ludwig-Maximilians - University of Munich1,020 enrolled1 locationNCT07504965
Recruiting
Not Applicable

Activity Tracking, Care Partner Co-participation, Text Reminders, Instructional Education, Video-Guided Physical Rehabilitation, and Exercise

Mild Dementia
NYU Langone Health100 enrolled1 locationNCT07321587
Recruiting

Assessing Cognitive Decline at Home

DementiaDementia AlzheimersMild Cognitive Impairment+3 more
Stanford University25 enrolled1 locationNCT06704971
Recruiting
Not Applicable

SHARE Adaptation Intervention for African-American Families

Mild DementiaModerate Dementia
Benjamin Rose Institute on Aging120 enrolled1 locationNCT07208162
Recruiting
Phase 2

Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease

Mild Cognitive Impairment (MCI)Mild DementiaAlzheimer's Disease
NeuroBiogen Co., Ltd114 enrolled8 locationsNCT07027072
Recruiting
Not Applicable

Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's Disease

Mild Cognitive ImpairmentMild Dementia
Ruijin Hospital180 enrolled1 locationNCT05887674
Recruiting
Not Applicable

Resistance Training to Individuals for Cognitive Impairment With Dementia

Mild Cognitive ImpairmentMild Dementia
University of Beira Interior80 enrolled1 locationNCT06185010